These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25561336)

  • 1. In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.
    Bontron S; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1664-70. PubMed ID: 25561336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases.
    Delbrück H; Bogaerts P; Kupper MB; Rezende de Castro R; Bennink S; Glupczynski Y; Galleni M; Hoffmann KM; Bebrone C
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5618-25. PubMed ID: 22908160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.
    Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Arakawa Y
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2905-10. PubMed ID: 15273099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and biochemical characterization of GES-16, a new GES-type β-lactamase with carbapenemase activity in Serratia marcescens.
    Streling AP; Barbosa PP; Marcondes MF; Nicoletti AG; Picão RC; Pinto EC; Marques EA; Oliveira V; Gales AC
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):147-151. PubMed ID: 29861147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
    Poirel L; Brinas L; Fortineau N; Nordmann P
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3593-7. PubMed ID: 16048994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802.
    Rejiba S; Limam F; Belhadj C; Belhadj O; Ben-Mahrez K
    Microb Drug Resist; 2002; 8(1):9-13. PubMed ID: 12002654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
    Moubareck C; Brémont S; Conroy MC; Courvalin P; Lambert T
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3579-81. PubMed ID: 19451292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P174E Substitution in GES-1 and GES-5 β-Lactamases Improves Catalytic Efficiency toward Carbapenems.
    Piccirilli A; Mercuri PS; Galleni M; Aschi M; Matagne A; Amicosante G; Perilli M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.
    Poirel L; Weldhagen GF; Naas T; De Champs C; Dove MG; Nordmann P
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2598-603. PubMed ID: 11502535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
    Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of IMP-10 metallo-beta-lactamase in hydrolysing various antipseudomonal beta-lactams.
    Zhao WH; Hu ZQ; Shimamura T
    J Med Microbiol; 2008 Aug; 57(Pt 8):974-979. PubMed ID: 18628498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
    Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and structural requirements for carbapenemase activity in GES-type β-lactamases.
    Stewart NK; Smith CA; Frase H; Black DJ; Vakulenko SB
    Biochemistry; 2015 Jan; 54(2):588-97. PubMed ID: 25485972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.
    Cantu C; Huang W; Palzkill T
    J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.
    Kimura S; Ishiguro M; Ishii Y; Alba J; Yamaguchi K
    Antimicrob Agents Chemother; 2004 May; 48(5):1454-60. PubMed ID: 15105092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
    Sanders CC; Sanders WE
    J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.
    Saral A; Leonard DA; Duzgun AO; Cicek AC; June CM; Sandalli C
    J Antibiot (Tokyo); 2016 Dec; 69(12):858-862. PubMed ID: 27168312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.